TLDR Truist Securities upgrades Biogen to Aquire from Set, elevating designate goal to $235 from $190 Upgrade comes forward of Phase 2 knowledge presentation for Alzheimer’s drug diranersen on July 14 Biogen inventory rose 1.3% to $201.63 in premarket trading Monday Truist added anguish-adjusted income forecasts for lupus drug litifilimab and felzartamab to its model […]
The publish Biogen (BIIB) Stock Will get Aquire Upgrade Before Alzheimer’s Drug Knowledge regarded first on CoinCentral…
Read More
Biogen (BIIB) Stock Will get Aquire Upgrade Before Alzheimer’s Drug Knowledge
Related Posts
Volkswagen Plans to Lower up to 100,000 Jobs as Ticket Crisis Deepens
TLDR Volkswagen CEO Oliver Blume urged workers the firm could...
Q32 Bio (QTTB) Stock Jumps 60% on Alopecia Drug Trial Win
TLDR Q32 Bio stock jumped ~60% after reporting particular 36-week...
Mint Inc (MIMI) Inventory Jumps 39% on Singapore Robotics Deal
TLDR MIMI stock surged over 39% Monday after asserting a...